Home The Word Brain	My Amedeo FAQ Privacy About
	CC Journal Club Our weekly journal club for junior residents and medical students

Cervical Cancer

Free Subscription Articles published in Clin Cancer Res Retrieve available abstracts of 10 articles: HTML format

Single Articles

March 2025
1. EERKENS AL, Esajas MD, Brummel K, Vledder A, et al
   Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade Cervical Intraepithelial Neoplasia: A Phase II Trial.
   Clin Cancer Res. 2025;31:1016-1026.
   PubMed     Abstract available
   
   
   December 2024
2. SEO A, Xiao W, Gjyshi O, Yoshida-Court K, et al
   Human Papilloma Virus Circulating Cell-Free DNA Kinetics in Cervical Cancer Patients Undergoing Definitive Chemoradiation.
   Clin Cancer Res. 2024 Dec 16. doi: 10.1158/1078-0432.CCR-24-2343.
   PubMed     Abstract available
   
   
   July 2024
3. BONFILL-TEIXIDOR E, Neva-Alejo A, Arias A, Cuartas I, et al
   Cervical Cancer Evades the Host Immune System Through the Inhibition of Type I Interferon and CXCL9 by LIF.
   Clin Cancer Res. 2024 Jul 30. doi: 10.1158/1078-0432.CCR-24-0385.
   PubMed     Abstract available
   
   
   May 2024
4. SHETH SS, Oh JE, Bellone S, Siegel ER, et al
   Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147).
   Clin Cancer Res. 2024;30:1768-1777.
   PubMed     Abstract available
   
   
   April 2024
5. SIVARS L, Jylha C, Crona Guterstam Y, Zupancic M, et al
   Cell-free human papillomavirus (HPV) DNA is a sensitive biomarker for prognosis and for early detection of relapse in locally advanced cervical cancer.
   Clin Cancer Res. 2024 Apr 26. doi: 10.1158/1078-0432.CCR-23-3941.
   PubMed     Abstract available
   
   
   
6. CHAMBERS L, Haight P, Chalif J, Mehra Y, et al
   Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-Oncology Research.
   Clin Cancer Res. 2024 Apr 25. doi: 10.1158/1078-0432.CCR-23-2570.
   PubMed     Abstract available
   
   
   February 2024
7. LOU H, Cai H, Huang X, Li G, et al
   Cadonilimab combined with chemotherapy with or without bevacizumab as first-line treatment in recurrent or metastatic cervical cancer (COMPASSION-13): a phase 2 study.
   Clin Cancer Res. 2024 Feb 19. doi: 10.1158/1078-0432.CCR-23-3162.
   PubMed     Abstract available
   
   
   January 2024
8. LUKOVIC J, Pintilie M, Han K, Fyles AW, et al
   An immune gene expression risk score for distant metastases after radiotherapy for cervical cancer.
   Clin Cancer Res. 2024 Jan 5. doi: 10.1158/1078-0432.CCR-23-2085.
   PubMed     Abstract available
   
   
   
9. OAKNIN A, Ghamande SA, Kasamatsu Y, Gil-Martin M, et al
   Phase 1 trial of first-line bintrafusp alfa in patients with locally advanced or persistent/recurrent/metastatic cervical cancer.
   Clin Cancer Res. 2024 Jan 2. doi: 10.1158/1078-0432.CCR-23-1829.
   PubMed     Abstract available
   
   
   August 2023
10. FRIEDMAN CF, Ravichandran V, Miller K, Vanderbilt C, et al
    Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets.
    Clin Cancer Res. 2023 Aug 29:CCR-23-1078. doi: 10.1158/1078-0432.CCR-23-1078.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.